India to Vietnam: Gliclazide Export Trade Route

The India to Vietnam Gliclazide corridor is one of India's established pharmaceutical export routes, with 136 shipments documented worth a combined $41.8M USD. The route is dominated by PANACEA BIOTEC PHARMA LIMITED, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's gliclazide manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $307.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with gliclazide's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 16.4%, placing it at rank #1 among India's top gliclazide export destinations globally.

On the import side, key buyers of Indian gliclazide in Vietnam include DANANG PHARMACEUTICAL MEDICAL EQUIP, DELTA IMPORT EXPORT MEDICAL CO., LT, CENTRAL PHARMACEUTICAL JOINT STOCK and 20 others. DANANG PHARMACEUTICAL MEDICAL EQUIP is the single largest importer with 21 shipments valued at $31.3M USD.

India's gliclazide exports to Vietnam are driven primarily by a handful of large-scale manufacturers. PANACEA BIOTEC PHARMA LIMITED with 26 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Vietnam benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — PANACEA BIOTEC PHARMA LIMITED, MICRO LABS LIMITED, IPCA LABORATORIES LIMITED — together account for 94% of total trade value on this route. The average shipment value of $307.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as glizym m tablets (each uncoated tablet contains gliclazide bp 80 mg + metforminhydrochloride ip 500 mg) b/n.18423026 to and h.l.med.: glycinorm 80mg tablets (gliclazide 80mg tablets) [each tab contains: gliclazide bp/ep-80mg] [pack:3x10's], suggesting that buyers in Vietnam tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DANANG PHARMACEUTICAL MEDICAL EQUIP is the largest importer with 21 shipments worth $31.3M USD — representing 75% of all gliclazide imports from India on this route. A total of 23 buyers are active on this corridor.